One study showed a significant increase in DAT binding in the midbrain in the group with improved depression compared with the group without improved depression [14], whereas the other showed no significant correlation between DAT binding and the change in depression scores with treatment [15]. This evidence concerns the gene SLC6A3 and depressive symptom measurement.